Upgrade to SI Premium - Free Trial

Alkermes plc (ALKS) Launches Investigational Product Designed for Initiation Onto ARISTADA for Treatment of Schizophrenia

October 26, 2017 7:44 AM
Alkermes plc (NASDAQ: ALKS) today unveiled Aripiprazole Lauroxil NanoCrystal® Dispersion (ALNCD), a novel, investigational product designed for initiation onto ARISTADA® ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Hot Corp. News Management Comments

Next Articles